Cargando…
Tumor specific regulatory T cells in the bone marrow of breast cancer patients selectively upregulate the emigration receptor S1P1
Regulatory T cells (Treg) hamper anti-tumor T-cell responses resulting in reduced survival and failure of cancer immunotherapy. Among lymphoid organs, the bone marrow (BM) is a major site of Treg residence and recirculation. However, the process governing the emigration of Treg from BM into the circ...
Autores principales: | Rathinasamy, Anchana, Domschke, Christoph, Ge, Yingzi, Böhm, Hans-Henning, Dettling, Steffen, Jansen, David, Lasitschka, Felix, Umansky, Ludmila, Gräler, Markus H., Hartmann, Jennifer, Herold-Mende, Christel, Schuetz, Florian, Beckhove, Philipp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406429/ https://www.ncbi.nlm.nih.gov/pubmed/28224210 http://dx.doi.org/10.1007/s00262-017-1964-4 |
Ejemplares similares
-
When Immune Cells Turn Bad—Tumor-Associated Microglia/Macrophages in Glioma
por: Roesch, Saskia, et al.
Publicado: (2018) -
HLA Class II tetramers reveal tissue-specific regulatory T cells that suppress T-cell responses in breast carcinoma patients
por: Schmidt, Hans-Henning, et al.
Publicado: (2013) -
Bone marrow expands the repertoire of functional T cells targeting tumor-associated antigens in patients with resectable non-small-cell lung cancer
por: Safi, Seyer, et al.
Publicado: (2019) -
B cell-regulated immune responses in tumor models and cancer patients
por: Fremd, Carlo, et al.
Publicado: (2013) -
MetaboDiff: an R package for differential metabolomic analysis
por: Mock, Andreas, et al.
Publicado: (2018)